Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
New England Biolabs Inc. has 11 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 11 distinct examiners across 9 distinct art units, reflecting broad prosecution coverage and multiple technical-unit assignments.
REGA, KYLE THOMAS is the busiest examiner, with 1 pending matter. No examiner concentration is shown, so portfolio management should emphasize centralized tracking of diverse office-action positions and careful coordination among the nine art units.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (9%) |
| §103 only | 3 (27%) |
| §102 only | 1 (9%) |
| §112 only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 1 | 62.8% | +42.6% |
| RILEY, JEZIA | 1 | 83.0% | +7.2% |
| SALMON, KATHERINE D | 1 | 42.7% | +38.2% |
| PRIEST, AARON A | 1 | 61.7% | +25.4% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.6% | +59.9% |
| SHIN, DANA H | 1 | 26.8% | +26.9% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 40.0% | +47.7% |
| HANDY, DWAYNE K | 1 | 63.0% | +24.9% |
| CASH, KAILEY ELIZABETH | 1 | 28.6% | +64.3% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 48.7% | +61.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907482 | Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA | CASH, KAILEY ELIZABETH | 127d overdue |
| 18323143 | Double-Stranded DNA Deaminases and Uses Thereof | BUCHANAN, BAILEY CHEYENNE | 12d |
| 18452104 | Rapid Diagnostic Test for LAMP | GIAMMONA, FRANCESCA FILIPPA | 71d |
| 18706431 | Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes | RILEY, JEZIA | — |
| 18562953 | An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase | SALMON, KATHERINE D | — |
| 18509884 | Analysis of Chromatin Using a Nicking Enzyme | PRIEST, AARON A | — |
| 18546896 | Compositions and Methods for Labeling Modified Nucleotides in Nucleic Acids | SHIN, DANA H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907482 | Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA | CASH, KAILEY ELIZABETH | 127d overdue |
| 18969910 | Programmable Cleavage of RNA | REGA, KYLE THOMAS | 30d overdue |
| 18155975 | Isolation of High Molecular Weight DNA Using Beads | HANDY, DWAYNE K | 6d |
| 18323143 | Double-Stranded DNA Deaminases and Uses Thereof | BUCHANAN, BAILEY CHEYENNE | 12d |
| 17820372 | Rolling Circle Reverse Transcription of Circular RNA | LIPPOLIS, ALEXANDRA ROSE | 22d |
| 18452104 | Rapid Diagnostic Test for LAMP | GIAMMONA, FRANCESCA FILIPPA | 71d |
| 18562953 | An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase | SALMON, KATHERINE D | — |
| 18509884 | Analysis of Chromatin Using a Nicking Enzyme | PRIEST, AARON A | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1682 | 2 |
| 1636 | 1 |
| 1671 | 1 |
| 1635 | 1 |
| 1798 | 1 |
| 1683 | 1 |
| 1637 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18969910 | Programmable Cleavage of RNA | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | 30d overdue | Pending | Dec 05, 2024 |
| 18706431 | Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes | RILEY, JEZIA | 1681 | §101§102§103Other | Non-Final OA | — | Pending | May 01, 2024 |
| 18562953 | An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase | SALMON, KATHERINE D | 1682 | §102§103 | Final Rejection | — | Pending | Nov 21, 2023 |
| 18509884 | Analysis of Chromatin Using a Nicking Enzyme | PRIEST, AARON A | 1681 | §102§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18452104 | Rapid Diagnostic Test for LAMP | GIAMMONA, FRANCESCA FILIPPA | 1671 | §103§112 | Final Rejection | 71d | Pending | Aug 18, 2023 |
| 18546896 | Compositions and Methods for Labeling Modified Nucleotides in Nucleic Acids | SHIN, DANA H | 1635 | §112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18323143 | Double-Stranded DNA Deaminases and Uses Thereof | BUCHANAN, BAILEY CHEYENNE | 1682 | §103§112 | Final Rejection | 12d | Pending | May 24, 2023 |
| 18155975 | Isolation of High Molecular Weight DNA Using Beads | HANDY, DWAYNE K | 1798 | §103 | Non-Final OA | 6d | Pending | Jan 18, 2023 |
| 17907482 | Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA | CASH, KAILEY ELIZABETH | 1683 | §103DP | Final Rejection | 127d overdue | Pending | Sep 27, 2022 |
| 17820372 | Rolling Circle Reverse Transcription of Circular RNA | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Final Rejection | 22d | Pending | Aug 17, 2022 |
| 17825346 | Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides | ZHANG, KAIJIANG | 1684 | §102Other | Final Rejection | 13d | Pending | May 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNew England Biolabs Inc. has 11 pending office actions as of November 2026, spread across 9 art units and 11 examiners.
Kyle Thomas Rega has the most, with 1 of New England Biolabs Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.